Emile Voest

Emile Voest

More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable to find these patients. That is why every patient with metastatic cancer should be genetically screened before starting treatment.

Back to news

More news

Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice 

Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice 

16-07-2024

By Laura Nederveen   In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …

Broader Testing in AYAs Helps 

Broader Testing in AYAs Helps 

15-11-2025

PhD candidates Jeffrey van Putten and Lina Lankhorst investigated whether AYAs (adolescents and young adults, diagnosed with cancer between the ages of …

Dutch House of Representatives votes for action of the Minister for arranging (provisional) reimbursement for whole genome sequencing-based DNA testing for most urgent groups of cancer patients

Dutch House of Representatives votes for action of the Minister for arranging (provisional) reimbursement for whole genome sequencing-based DNA testing for most urgent groups of cancer patients

25-02-2021

On February 25 2021, the Dutch House of Representatives adopted a motion approving reimbursement on a provisional basis of a …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl